Haemonetics 3rd Quarter Fiscal Year 2022 Earnings Release Available on Investor Relations Website
Haemonetics Corporation (NYSE: HAE) announced its third quarter fiscal 2022 financial results, concluding on January 1, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Haemonetics Corporation (NYSE: HAE) announced its third quarter fiscal 2022 financial results, concluding on January 1, 2022. The details are accessible on its Investor Relations website. A conference call will take place on February 8, 2022, at 8:00 a.m. EST to discuss these results, with a live webcast and replay available for a year. Haemonetics specializes in innovative medical products and solutions aimed at enhancing patient care and reducing healthcare costs across blood and plasma collection, surgical suites, and hospital transfusion services.
Details
News Market Reaction – HAE
The recorded move for HAE in the trading session of this news was +16.16%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Feb. 8, 2022 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal 2022, which ended January 1, 2022, are available on its Investor Relations website.
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. EST on February 8, 2022. The conference call and webcast can be accessed with the following information:
- U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
- Conference ID required for access: 1649685
- A live webcast of the call can be accessed on Haemonetics' Investor Relations website or via the following link: https://edge.media-server.com/mmc/p/qdj4xoqw
In addition, the Company has posted to its Investor Relations website the earnings release and analytical tables and supplemental information that will be referenced on its conference call and webcast, direct links to which are available below.
Direct link to 3Q FY22 Earnings Release:
https://haemonetics.gcs-web.com/static-files/a59812dd-079f-499d-b726-fea541f2555e
Direct link to 3Q FY22 Analytical Tables and Supplemental Information:
https://haemonetics.gcs-web.com/static-files/ef7b55ef-4438-44dc-ab9c-0574a6bad75f
A replay of the conference call and webcast will be available for one year beginning on February 8, 2022 at 11:00 a.m. EST using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contact | Media Contact |
Olga Guyette, Director-Investor Relations | Josh Gitelson, Director-Global Communications |
(781) 356-9763 | (781) 356-9776 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-3rd-quarter-fiscal-year-2022-earnings-release-available-on-investor-relations-website-301476839.html
SOURCE Haemonetics Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.